Ligand validation:3A4L

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3A4L_EDO_B_262	76%	72%	0.095	0.929	0.38	0.71	-	-	0	0	100%	1
3A4L_EDO_A_262	62%	88%	0.138	0.93	0.5	0.17	-	-	0	0	100%	1
3A4L_EDO_A_261	38%	74%	0.188	0.891	0.37	0.63	-	-	4	0	100%	1
3A4L_EDO_B_261	15%	78%	0.218	0.777	0.45	0.44	-	-	1	0	100%	1
3A4M_EDO_B_263	76%	61%	0.114	0.951	0.37	1.09	-	-	3	0	100%	1
3A4N_EDO_A_261	56%	69%	0.202	0.974	0.28	0.9	-	-	0	0	100%	1
2G8S_EDO_A_3016	100%	84%	0.02	0.992	0.42	0.35	-	-	0	0	100%	0.5
3DPJ_EDO_F_193	100%	76%	0.023	0.995	0.41	0.53	-	-	1	0	100%	1
4EYG_EDO_A_402	100%	81%	0.024	0.995	0.44	0.39	-	-	0	0	100%	1
4NMU_EDO_D_206	100%	92%	0.025	0.997	0.38	0.14	-	-	0	0	100%	1
4Q6J_EDO_A_302	100%	82%	0.013	0.999	0.37	0.42	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.